|
GB1422263A
(en)
*
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
|
US4585777A
(en)
*
|
1984-02-07 |
1986-04-29 |
A/S Ferrosan |
(-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
|
|
US5167948A
(en)
*
|
1987-08-07 |
1992-12-01 |
Mallinckrodt Medical, Inc. |
Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5708035A
(en)
|
1991-02-04 |
1998-01-13 |
Sepracor Inc. |
Methods of use and compositions of R(-) fluoxetine
|
|
US5384327A
(en)
|
1992-12-22 |
1995-01-24 |
Mcneilab, Inc. |
Anticonvulsant sorbopyranose sulfamates
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
AU707748B2
(en)
|
1994-03-25 |
1999-07-22 |
Isotechnika Inc. |
Enhancement of the efficacy of drugs by deuteration
|
|
US5597826A
(en)
*
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
GB9514842D0
(en)
|
1995-07-20 |
1995-09-20 |
Smithkline Beecham Plc |
Novel formulation
|
|
US5958429A
(en)
|
1996-08-16 |
1999-09-28 |
Eli Lilly And Company |
Potentiation of serotonin response
|
|
UA56185C2
(uk)
|
1996-09-30 |
2003-05-15 |
Пфайзер Інк. |
Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
|
|
US5776969A
(en)
|
1997-02-27 |
1998-07-07 |
Eli Lilly And Company |
Treatment of sleep disorders
|
|
CA2287397A1
(en)
|
1997-04-24 |
1998-10-29 |
Merck Sharp & Dohme Limited |
Use of an nk-1 receptor antagonist and an ssri for treating obesity
|
|
IT1291320B1
(it)
|
1997-05-08 |
1999-01-07 |
Borregaard Italia Spa |
Procedimento per la preparazione di composti aromatici contenenti un sistema eterociclico
|
|
SK283394B6
(sk)
*
|
1997-06-10 |
2003-07-01 |
Synthon B. V. |
Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
|
|
KR20010030860A
(ko)
|
1997-10-03 |
2001-04-16 |
캐리 메디컬 코퍼레이션 |
니코틴 리셉터 길항제, 및 항-진정제 또는 항-불안 약물을함유하는 니코틴 중독치료용 조성물
|
|
US6403597B1
(en)
|
1997-10-28 |
2002-06-11 |
Vivus, Inc. |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
|
|
DE69919142T2
(de)
|
1998-03-17 |
2005-01-20 |
Pfizer Products Inc., Groton |
Bicyclo [2.2.1] heptane und verwandte verbindungen
|
|
US20030187269A1
(en)
*
|
1998-04-17 |
2003-10-02 |
Curzons Alan David |
Novel process
|
|
GB9817195D0
(en)
*
|
1998-08-07 |
1998-10-07 |
Smithkline Beecham Plc |
Novel process
|
|
US6376531B1
(en)
*
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
|
US6440710B1
(en)
*
|
1998-12-10 |
2002-08-27 |
The Scripps Research Institute |
Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
|
|
EP1146871A4
(en)
|
1999-01-28 |
2002-04-17 |
Bristol Myers Squibb Co |
HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS
|
|
US20030055070A1
(en)
|
1999-07-01 |
2003-03-20 |
Wilma Harrison |
Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction
|
|
GB9916187D0
(en)
|
1999-07-09 |
1999-09-08 |
Smithkline Beecham Plc |
Novel process
|
|
IL137937A0
(en)
|
1999-08-27 |
2001-10-31 |
Pfizer Prod Inc |
A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
|
|
EP1104760B1
(en)
*
|
1999-12-03 |
2003-03-12 |
Pfizer Products Inc. |
Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
|
|
EP1134290A3
(en)
*
|
2000-03-14 |
2004-01-02 |
Pfizer Products Inc. |
Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors
|
|
US20010036943A1
(en)
|
2000-04-07 |
2001-11-01 |
Coe Jotham W. |
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
|
|
US20040229911A1
(en)
|
2000-05-17 |
2004-11-18 |
Pfizer Inc |
New pharmaceutical combinations for NOS inhibitors
|
|
DOP2001000154A
(es)
|
2000-05-25 |
2002-05-15 |
Pfizer Prod Inc |
Combinación de secretagogos de hormona del crecimiento y antidepresivos
|
|
EP1181933A3
(en)
|
2000-06-29 |
2002-04-10 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating or increasing appetite
|
|
US6369051B1
(en)
|
2000-07-06 |
2002-04-09 |
American Home Products Corporation |
Combinations of SSRI and estrogenic agents
|
|
US20020077323A1
(en)
|
2000-07-12 |
2002-06-20 |
Mclean Stafford |
Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies
|
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6436938B1
(en)
*
|
2001-01-22 |
2002-08-20 |
Pfizer Inc. |
Combination treatment for depression
|
|
US6720003B2
(en)
*
|
2001-02-16 |
2004-04-13 |
Andrx Corporation |
Serotonin reuptake inhibitor formulations
|
|
US6696450B2
(en)
|
2001-04-04 |
2004-02-24 |
Wyeth |
Serotonergic agents with long-acting in vivo effects
|
|
US6656951B2
(en)
|
2001-04-24 |
2003-12-02 |
Wyeth |
8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
|
|
US6780860B2
(en)
|
2001-04-26 |
2004-08-24 |
Wyeth |
Azabicyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
|
|
WO2002088132A1
(en)
|
2001-04-26 |
2002-11-07 |
Wyeth |
Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-ht1aantagonists
|
|
US6861427B2
(en)
|
2001-04-26 |
2005-03-01 |
Wyeth |
Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
|
|
US6815448B2
(en)
|
2001-05-07 |
2004-11-09 |
Wyeth |
Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-HT1A antagonists
|
|
US6737042B2
(en)
|
2001-05-24 |
2004-05-18 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
WO2003022283A1
(en)
|
2001-09-13 |
2003-03-20 |
Schering Corporation |
Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
|
|
US7019010B2
(en)
|
2001-09-27 |
2006-03-28 |
Novertis Ag |
Combinations
|
|
AU2002352868A1
(en)
|
2001-11-27 |
2003-06-10 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
US7084156B2
(en)
|
2001-11-27 |
2006-08-01 |
Merck & Co., Inc. |
2-Aminoquinoline compounds
|
|
US20050014848A1
(en)
|
2002-01-23 |
2005-01-20 |
Pfizer Inc. |
Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
|
|
AU2003209388A1
(en)
|
2002-01-29 |
2003-09-02 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
AR039084A1
(es)
|
2002-03-13 |
2005-02-09 |
Schering Corp |
Antagonistas nk1
|
|
TW200413273A
(en)
*
|
2002-11-15 |
2004-08-01 |
Wako Pure Chem Ind Ltd |
Heavy hydrogenation method of heterocyclic rings
|
|
DE10261807A1
(de)
*
|
2002-12-19 |
2004-07-01 |
Turicum Drug Development Ag |
Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel
|
|
US20040224943A1
(en)
|
2003-02-19 |
2004-11-11 |
Leventer Steven M. |
Method of lowering body temperature with (R) - 2,3-benzodiazepines
|
|
BRPI0411891A
(pt)
|
2003-06-27 |
2006-08-29 |
Pfizer Prod Inc |
pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3
|
|
US20050070577A1
(en)
|
2003-07-03 |
2005-03-31 |
Pfizer Inc. |
Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
|
|
US20050080084A1
(en)
|
2003-07-11 |
2005-04-14 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage
|
|
WO2005007111A2
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
|
EP1660079A2
(en)
|
2003-08-22 |
2006-05-31 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia
|
|
US7517900B2
(en)
|
2003-10-10 |
2009-04-14 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
ATE360630T1
(de)
|
2003-12-19 |
2007-05-15 |
Bristol Myers Squibb Co |
Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
|
|
WO2005107716A1
(en)
|
2004-03-25 |
2005-11-17 |
Cadila Healthcare Limited |
Controlled release paroxetine-containing tablets based on a core and a coating
|
|
FR2869033B1
(fr)
|
2004-04-20 |
2006-06-02 |
Rhodia Chimie Sa |
Procede de preparation de methylenedioxybenzene
|
|
US20050266082A1
(en)
|
2004-05-26 |
2005-12-01 |
Patel Satishkumar A |
Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
|
|
KR100920856B1
(ko)
|
2004-11-30 |
2009-10-09 |
(주)아모레퍼시픽 |
선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
|
|
CN101146521A
(zh)
|
2005-03-14 |
2008-03-19 |
太阳医药高级研究有限公司 |
提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
|
|
KR20070009934A
(ko)
|
2005-07-16 |
2007-01-19 |
주식회사 씨티씨바이오 |
염산 파록세틴 서방정 및 이의 제조방법
|
|
US20080033011A1
(en)
*
|
2005-07-29 |
2008-02-07 |
Concert Pharmaceuticals Inc. |
Novel benzo[d][1,3]-dioxol derivatives
|
|
US7863274B2
(en)
*
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
|
KR101380190B1
(ko)
*
|
2005-07-29 |
2014-04-11 |
콘서트 파마슈티컬즈, 인크. |
벤조 〔ｄ〕〔１,３〕―디옥솔 유도체
|
|
BRPI0615972A2
(pt)
*
|
2005-07-29 |
2011-05-31 |
Concert Pharmaceuticals Inc |
composto isolado, mistura, composição, item de manufatura, uso de um composto, método para determinar a concentração do composto em uma amostra biológica, kit de diagnóstico e método para avaliar a estabilidade metabólica de um composto
|
|
WO2007015270A2
(en)
|
2005-08-02 |
2007-02-08 |
Lupin Limited |
Novel controlled release compositions of selective serotonin reuptake inhibitors
|
|
CN101309917B
(zh)
|
2005-10-06 |
2013-09-11 |
奥斯拜客斯制药有限公司 |
具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
|
|
WO2007058998A2
(en)
*
|
2005-11-14 |
2007-05-24 |
Auspex Pharmaceuticals, Inc. |
Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
|
|
US7750168B2
(en)
*
|
2006-02-10 |
2010-07-06 |
Sigma-Aldrich Co. |
Stabilized deuteroborane-tetrahydrofuran complex
|
|
JO2630B1
(en)
|
2006-04-13 |
2012-06-17 |
نوفارتيس ايه جي |
Organic compounds
|
|
US20090291958A1
(en)
|
2006-06-08 |
2009-11-26 |
Auspex Pharmaceuticals, Inc. |
Substituted PDE5 inhibitors
|
|
WO2008016677A2
(en)
*
|
2006-08-02 |
2008-02-07 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of deuterated amphetamines
|
|
WO2008030382A1
(en)
*
|
2006-09-05 |
2008-03-13 |
Schering Corporation |
Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
|
|
AU2008299921B2
(en)
|
2007-09-13 |
2012-03-01 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
|
US20110257260A1
(en)
*
|
2009-07-21 |
2011-10-20 |
Auspex Pharmaceuticals, Inc. |
3,4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor
|